No Abstract

Background: A common way of describing UK National Institute for Health and Clinical Excellence (NICE) decisions is to distinguish between cases where NICE recommended use of a healthcare technology by all relevant patients ('yes'); those where it did not recommend use ('no'); and those where...

HASH(0x1009c41f0)

This paper critiques 'needs assessment' as a basis for allocating public funding of health and disability services and discusses an alternative economics-based approach. In essence, the former approach ignores the effects on health outcomes of health care spending at the margin while the latter...

The purpose of this paper is to provide an account of the full set of possible means by which value based pricing (VBP) might be operationalised; to describe and categorise them by developing a taxonomy of approaches; to give an initial assessment of the challenges, pros and cons that each of the...

Background: The UK Government is proposing to include “burden of illness” in its proposed scheme for the value‐based pricing (VBP) of branded medicines. The VBP consultation document suggests that medicines that tackle diseases associated with high levels of burden of illness will be...